COR logo

CORCencora Inc.

$275.04
$4.72
(1.75%)
Today
Closed $275.04
$4.03
(1.47%)
After Hours
Updated: 07:49 PM EDT
EarningsAug 5
Mkt Cap$53.51B
Vol1.32M
News
all
press releases
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
COR bets on MSOs, specialty logistics and AI tools to deepen ties beyond distribution???even as GLP-1 mix and pricing swings cloud results.
Zacks
News Placeholder
More News
News Placeholder
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know
The mean of analysts' price targets for Cencora (COR) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR PR Newswire NEW YORK, May 28, 2026 NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
News Placeholder
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?
CAH and COR are betting big on specialty pharma, but Cardinal Health???s stronger growth, raised outlook, and broader expansion may set it apart.
Zacks
News Placeholder
Cencora Names Eva Boratto EVP, CFO; Reaffirms FY26 Adj. EPS Range
(RTTNews) - Global pharmaceutical solutions provider Cencora, Inc. (COR) Wednesday announced the appointment of Eva Boratto as executive vice president and chief financial officer, effective June 29, 2026...
Nasdaq News: Markets
News Placeholder
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
Cencora, Inc. (NYSE: COR) today announced Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 29, 2026. Ms. Boratto succeeds James F. Cleary, who will be retiring from his role as Executive Vice President and Chief Financial Officer...
Business Wire
News Placeholder
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today
read more...
Benzinga
News Placeholder
Cencora Raises FY26 Outlook; Plans Up To $2 Bln Addl. Share Repurchase
(RTTNews) - Cencora Inc. (COR), a pharmaceutical company, announced that it has raised the lower end of its fiscal 2026 adjusted earnings outlook. Further, the company said its Board of Directors, on May 20th, authorized additional up to $2.0 billion share repurchase program...
Nasdaq News: Markets
News Placeholder
Cencora Announces Updated Fiscal Year 2026 Financial Outlook
Cencora, Inc. (NYSE: COR) today updated its fiscal year 2026 financial guidance as a result of recent opportunistic share repurchases. Cencora now expects adjusted diluted earnings per share to be in the range of $17.70 to $17.90, up from the previous range of $17.65 to $17.90. The opportunistic...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.